Diagnostic and Prognostic Biomarkers in Parkinson Disease
NCT00653783 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2008-12-31
Summary
The overall goal of PROBE is to evaluate the feasibility and potential utility of three markers (alpha-synuclein, transcriptomic profiles and olfactory function) to determine the risk or prognosis of PD.
Conditions
- Parkinson Disease
- Multiple System Atrophy
- Progressive Supranuclear Palsy
Sponsors & Collaborators
-
United States Department of Defense
collaborator FED -
The Parkinson Study Group
lead NETWORK
Principal Investigators
-
Bernard Ravina, MD · University of Rochester
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-08-31
- Primary Completion
- 2008-07-31
Countries
- United States
Study Locations
More Related Trials
-
Parkinson's Disease Biomarker Study
NCT06812702 ·Status: COMPLETED
-
Biomarkers in Parkinsonian Syndromes
NCT02114242 ·Status: RECRUITING
-
Research on Novel Biomarkers for Early Diagnosis of Parkinson's Disease:An Observational, Multicenter, Non-Randomized Controlled Study
NCT06232772 ·Status: RECRUITING
-
Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression
NCT01141023 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Markers in Parkinson's Disease
NCT00088335 ·Status: COMPLETED
-
Parkinson's Disease Biomarker Program
NCT01767818 ·Status: COMPLETED
-
A Non-interventional Study for the Collection of Biospecimens From Patients With Parkinson's Disease
NCT04893083 ·Status: TERMINATED
-
Biomarkers in Parkinsonian Syndromes
NCT06501469 ·Status: RECRUITING
-
A Study Evaluating Potential Screening Tools for Detecting Parkinson Disease
NCT00387075 ·Status: UNKNOWN ·Phase: PHASE2
-
Research of Biomarkers in Parkinson Disease
NCT00465790 ·Status: COMPLETED
-
Analysis of the Prognostic Role of Epigenetic Biomarkers in Relation to the Motor Decline in Parkinson's Disease
NCT05384522 ·Status: NOT_YET_RECRUITING
-
Serum Biomarkers in Parkinson's Disease at Different Stages
NCT05769699 ·Status: RECRUITING ·Phase: NA
-
Unstructured Eye Tracking as a Diagnostic and Prognostic Biomarker in Parkinsonian Disorders
NCT05638477 ·Status: UNKNOWN ·Phase: NA
-
NMR Based Metabolomic Study of Serum Biomarkers in Patients With Parkinson's Disease and Atypical Parkinsonian Syndrome
NCT06490926 ·Status: RECRUITING
-
SudoScan as a Biomarker of Parkinson's Disease
NCT02767037 ·Status: COMPLETED ·Phase: NA
-
Biomarkers in Neural Disorders
NCT02761707 ·Status: COMPLETED
-
Neuroplasticity in Parkinson's Disease
NCT05286736 ·Status: RECRUITING
-
Cell Studies of Parkinson's Disease
NCT00076505 ·Status: COMPLETED
-
Misfolded Proteins in the Skin of People With Parkinson's Disease and Other Parkinsonism
NCT04518059 ·Status: COMPLETED
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
NCT07204652 ·Status: RECRUITING
-
Quantification of Parkinson's Disease Patients As a Biomarker for Classification, Prediction and Response to Treatment
NCT06586320 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.
NCT01380899 ·Status: COMPLETED
-
Evaluation of Autonomic, Imaging and Genetic Markers for Parkinson-related Dementia : Longitudinal Assessment of a PD Cohort.
NCT06156917 ·Status: COMPLETED
-
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
NCT05699460 ·Status: ACTIVE_NOT_RECRUITING
-
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
NCT04477785 ·Status: RECRUITING